Cite
Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas
MLA
P, Canal, et al. “Plasma and Cellular Pharmacokinetics of Mitoxantrone in High-Dose Chemotherapeutic Regimen for Refractory Lymphomas.” Cancer Research, vol. 53, no. 20, Oct. 1993. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a532341b4f4c6b439ec38874015950f2&authtype=sso&custid=ns315887.
APA
P, C., M, A., E, C., S, G., F, H., C, M., D, S., G, L., G, H., & R, B. (1993). Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Research, 53(20).
Chicago
P, Canal, Attal M, Chatelut E, Guichard S, Huguet F, Muller C, Schlaifer D, Laurent G, Houin G, and Bugat R. 1993. “Plasma and Cellular Pharmacokinetics of Mitoxantrone in High-Dose Chemotherapeutic Regimen for Refractory Lymphomas.” Cancer Research 53 (20). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a532341b4f4c6b439ec38874015950f2&authtype=sso&custid=ns315887.